Post-IPO Equity - Alnylam Pharmaceuticals - Mar 28, 2011 Funding Round Profile - Cointime

Bitcoin $79,343.10 +3.60%
Ethereum $3,189.75 +4.56%
BNB $634.03 +1.06%
Optimism $1.67 +2.09%
Arbitrum $0.64 +4.42%
Solana $204.99 +1.49%
Polygon $0.40 +4.37%
Cosmos $5.19 +8.74%
Avalanche $31.86 +7.15%

Bitcoin $79,343.10 +3.60%
Ethereum $3,189.75 +4.56%
BNB $634.03 +1.06%
Optimism $1.67 +2.09%
Arbitrum $0.64 +4.42%
Solana $204.99 +1.49%
Polygon $0.40 +4.37%
Cosmos $5.19 +8.74%
Avalanche $31.86 +7.15%

Alnylam Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 10M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Takeda	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 7, 2003	Private Equity（PE）	$ 24.60M	Merck,ARCH Venture Partners	Detail